M. Eggert

Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry

D. Badesch, D. Ivy, S. Mathai, 2021, Pulmonary circulation.

Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat

H. Palevsky, S. Mathai, N. Hill, 2022, Pulmonary circulation.

Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.

R. Benza, A. Frost, H. Farber, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

PH Grand Rounds: Giant Pulmonary Artery Aneurysm and Severe Multifactorial Pulmonary Hypertension: A Case Report

D. Levine, R. Gattani, M. Eggert, 2020 .

Infiltrative lung disease due to noncytotoxic agents.

J. A. Cooper, M. Eggert, B. Lock, 2004, Clinics in chest medicine.

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension

H. Palevsky, G. Ramani, C. Deng, 2022, Pulmonary circulation.

Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.

R. Kronmal, N. Kolaitis, R. Benza, 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)

S. Mathai, J. Ryan, O. Shlobin, 2021, Pulmonary circulation.

Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry

D. Badesch, D. Ivy, S. Mathai, 2020, Pulmonary circulation.

Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document

H. Palevsky, M. Chakinala, R. Bourge, 2017, Pulmonary circulation.

Health Related Quality of Life and Hospitalizations In Chronic Thromboembolic Pulmonary Hypertension Versus Idiopathic Pulmonary Arterial Hypertension: An Analysis from the Pulmonary Hypertension Association (PHAR)

D. Badesch, S. Mathai, J. Ryan, 2021, medRxiv.

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension A Double-Blind Placebo-controlled Clinical Trial

M. Yigla, Akram Khan, C. Bao, 2020 .

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

M. Yigla, Akram Khan, C. Bao, 2019, American journal of respiratory and critical care medicine.